NCT00415805View on ClinicalTrials.gov

Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent

PHASE3CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

February 28, 2009

Conditions
Steno-occlusive Disease
Interventions
DRUG

Multihance

0.5 Molar, single injection at 0.2 mL/kg

DRUG

vasovist

0.25 molar single injection 0.03 ml/kg

Trial Locations (1)

20134

Bracco Imaging, S.p.A, Milan

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY